Integrations

Data Management Platform
Other

Indegene SmartCare Product Overview

Indegene drives data-driven digital transformation and omnichannel HCP engagement. Exceptional patient services are delivered by this digital-first life sciences commercialization company.

How satisfied the customers are with Indegene SmartCare use-cases

Reviews

"...Indegene's SmartCare helps decision makers manage and execute on multiple business challenges including pay-for-performance, contract negotiations, clinical integration, resource utilization, provider profiling, and benchmarking, as well as tracking quality and core measures among other aspects of population health with ease, accuracy, and speed...." Peer review

Indegene SmartCare Customer Insights, Testimonials and Case Studies

Indegene SmartCare Features

  • Low
  • Medium
  • High
FEATURE RATINGS AND REVIEWS
AI Powered

4.03/5 ★

Read Reviews (9)
Custom Reports

4.26/5 ★

Read Reviews (15)
Analytics

4.22/5 ★

Read Reviews (20)
CAPABILITIES RATINGS AND REVIEWS
AI Powered

4.03/5 ★

Read Reviews (9)
Custom Reports

4.26/5 ★

Read Reviews (15)
Analytics

4.22/5 ★

Read Reviews (20)

Indegene SmartCare Integrations

Indegene SmartCare integrates with a wide range of software applications through its robust data import and export capabilities.

Data Import

3.96/5 ★

Read Reviews (4)
Data Export

3.16/5 ★

Read Reviews (2)

ataccama

4.22 5
 ★ ★ ★ ★ ★  ☆ ☆ ☆ ☆ ☆

Claravine

3.92 5
 ★ ★ ★ ★ ★  ☆ ☆ ☆ ☆ ☆

Software Failure Risk Guidance

?

for Indegene SmartCare

Top Failure Risks for Indegene SmartCare

Indegene News

Financial
 

Indegene Q3 results: Revenue surges 31% to 942 crore but profit, margins dip

Indegene's Q3 FY26 results show a 30.8% revenue increase to 942 crore, marking its first $100 million-plus revenue quarter. Despite this, net profit fell 6.2% to 102.9 crore, and operating margins narrowed to 17%. Key achievements include three customers surpassing $25 million in annual revenue. Recent acquisitions of BioPharm and Warn & Co aim to enhance domain expertise.

Read more →
Financial
 

Indegene Board to Approve Q3 2026 Financial Results

Indegene's Board of Directors will meet on January 29, 2026, to review and approve the unaudited financial results for Q3 2026. The meeting will also address share allotment under the RSU Scheme 2020. The trading window for company securities is closed until 48 hours after the results are declared.

Read more →
Partnership
 

Indegene Selects Verified Market Research to Gain Strategic Insight into the Conjunctivitis Allergy Market

Indegene partnered with Verified Market Research to obtain strategic insights into the conjunctivitis allergy market. This collaboration aimed to support Indegene's advisory role for a client by providing detailed market sizing, segmentation, and competitive analysis. The insights helped shape the client's portfolio expansion strategy, demonstrating Indegene's commitment to delivering precise and actionable data.

Read more →
Company
 

Indegene expands its consulting practice to support life sciences organizations

Indegene has expanded its consulting practice to assist life sciences organizations in managing large-scale transformations. The company has appointed Gobin Chandra as the head of its Integrated Consulting Practice. This expansion includes acquiring UK-based WARN & Co. to enhance its transformation consulting capabilities.

Read more →

Indegene Profile

Company Name

Indegene

Company Website

https://www.indegene.com/

HQ Location

Princeton, New Jersey

Employees

5001-10000

Social

Facebook Linkedin Twitter

Financials

PRIVATE